Sunday, June 01, 2014 8:25:20 AM
re YMB post: "smegggy • May 30, 2014 7:24 AM
Juventas Therapeutics
On May 19 this was announce.Phase 2 JVS-100 stem cell therapy to reduce the size of a damaged heart is a success. Next step Phase 3 next summer. This Cleveland Clinic spinoff that is privately held is located in the same stem cell corridor as ATHX . Located about a mile from each other. So this is big news for stem cell research in Cleveland .I wish they would IPO before Phase 3. Keep in mind ATHX and Juventas are on friendly terms in the stem cell associations . Check out National Center for Stem Cell Research ( for which ATHX is a founding member w/Cleve Clinic and Case)Juventas has had lots of backing given to them by a large Japanese pharma. Google the results and info on this private concern. See the dotted lines that connects ATHX the Cleve Clinic and Juventas. . This could be the reason ATHX is moving and will continue to rally"
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM